WOBENSMITH JOHN C

GNK Chairman/CEO John C Wobensmith sells 39,244 shares ($928.5K) at $23.66; stock up 25.1% in 90d

WOBENSMITH JOHN C, as Chairman, CEO, and President, sold 39,244 shares of GNK at $23.66 on 2026-02-23, reducing his holdings by 6.5% to 564,617 shares. The sale occurred as the stock is near its 52-week high of $23.96 and has gained 25.1% over the past 90 days. Across his five prior sales at GNK, WOBENSMITH achieved a 20% well-timed rate at the 90-day mark—meaning only 1 of 5 prior sales preceded stock declines. His cross-ticker track record shows a 16.67% well-timed rate at 90 days, though his average 90-day return after sells across all tickers is positive at +4.6%, indicating his prior sales have generally not preceded sustained declines. The company reported negative net income of $-1.1M in its latest quarter and is unprofitable on a full-year basis, with annual revenue declining 19.1% year-over-year, creating a disconnect between deteriorating fundamentals and recent strong price momentum.

CEO John C. Wobensmith sold 39,000 shares for $712,760 across 2 transactions at GNK; part of pattern of recent sales at elevated price levels.

John C. Wobensmith, Chairman, CEO, and President, executed 2 separate sales totaling 39,000 shares for $712,760.00 at an blended average price of $18.28 on September 12 and 15, 2025. This represents a -7.1% reduction in his post-transaction holdings of 506,733 shares. The sale prices of $18.12 and $18.44 fall within the 52-week range of $11.36–$19.50 and are only -6.5% from the 52-week high, placing these sales near recent peaks. Notably, this filing reflects part of a cluster of four recent sales at GNK between September 8–12, 2025, all at similar price levels. His broader cross-ticker track record shows 4 prior sells with a 90-day well-timed rate of 0.00%, indicating prior sales at this company have not preceded declines; the single prior same-ticker sale on 2024-02-23 returned +9.3% over 90 days (poorly timed, as the stock rose after). The fundamental context shows negative net income of $-6.8M in the latest quarter against revenue of $80.9M, paired with a high P/E of 50.64, which may inform the pattern of near-peak liquidation by the CEO.

GNK Chairman/CEO John C. Wobensmith sold 62,752 shares (62.8K) for $1,131,238.72 in 2 transactions at $18.01-$18.11, reducing stake by 10.3%

John C. Wobensmith, who holds the combined roles of Chairman, CEO, and President, executed 2 separate sales totaling 62,752 shares (62.8K shares) for $1,131,238.72, with a blended average price of $18.03 across the transactions on 2025-09-08 and 2025-09-09. His post-transaction holdings total 545,733 shares, representing a net reduction of 10.3% versus pre-transaction holdings of 608,485 shares. The disposition reflects a material liquidation of equity by the company's most senior executive, occurring in a concentrated two-day window. Without additional context regarding scheduled plan activity or strategic rationale, the magnitude of this reduction warrants investor attention to understand the underlying business drivers.